Your browser doesn't support javascript.
loading
Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in vitro models of hepatic metabolism.
Law, Rebecca; Lewis, David; Hain, Daniel; Daut, Rachel; DelBello, Melissa P; Frazier, Jean A; Newcorn, Jeffrey H; Nurmi, Erika; Cogan, Elizabeth S; Wagner, Susanne; Johnson, Holly; Lanchbury, Jerry.
Afiliação
  • Law R; Myriad Neuroscience, Mason, OH, USA.
  • Lewis D; Myriad Neuroscience, Mason, OH, USA.
  • Hain D; Myriad Neuroscience, Mason, OH, USA.
  • Daut R; Myriad Neuroscience, Mason, OH, USA.
  • DelBello MP; Department of Psychiatry and Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Frazier JA; Eunice Kennedy Shriver Center, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Newcorn JH; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Nurmi E; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, Los Angeles, CA, USA.
  • Cogan ES; Myriad Genetics, Salt Lake City, UT, USA.
  • Wagner S; Myriad Genetics, Salt Lake City, UT, USA.
  • Johnson H; Myriad Neuroscience, Mason, OH, USA.
  • Lanchbury J; Myriad Genetics, Salt Lake City, UT, USA.
Xenobiotica ; 52(7): 676-686, 2022 Jul.
Article em En | MEDLINE | ID: mdl-36317558

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article